Cannabis 2.0 Sales Launch Today!

Now that Canadian shelves are stuffed with all kinds of new cannabis products, what should investors really expect?‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  [Profit Trends]( [Beyond the Bong](  Cannabis 2.0 Sales Launch Today and Pot Stocks Are Feeling the Joy Matthew Carr | Chief Trends Strategist | The Oxford Club  [Secret "Shark Investing Blueprint" Could Hand You A Massive Fortune]( [Shark Tank Analyst](Original Shark Tank star Kevin Harrington is sharing [his personal blueprint]( to investing... The same blueprint he personally used to go from a working class kid in Ohio... To a multimillionaire living the dream life. He certainly didn't start with much, and you don't need to either. All it takes is a single $50 bill... and your life may never be the same again. [Click here to see how you can access it.](  [Matthew Carr]Today's the day! Cannabis 2.0 sales finally kick off in Canada! These are high-margin products - beverages, edibles, topicals, vape pens and more. And as I've been telling investors for years, once these products hit the shelves, they'll buoy the earnings and revenue of Canadian licensed producers. So... just how big of an impact will Cannabis 2.0 have? Well, projections are for Canada's marijuana market to be worth $3.7 billion in 2020. That's more than double the $1.6 billion in 2019. And, as we've closed in on today's national rollout, Canada's "Big Seven" have rebounded...  [Chart - Canada's Big Seven]  Canopy Growth Corp. (NYSE: CGC) is leading the pack, up nearly 35% over the past month. Constellation Brands (NYSE: STZ) chief financial officer David Klein was named the Canadian producer's new CEO. This Cannabis 2.0 opportunity is why Constellation poured $4 billion into Canopy. And why it's taking the helm. But now that Canadian shelves are stuffed with all kinds of new cannabis products - drawing in new customers and offering new opportunities - what should investors really expect?  [Take a Look at This Strange Device]( [Lynchpin Device](It can fit in the palm of your hand... Weighs less than a can of soup... And uses less energy than a night light. But it could change EVERYTHING. [Discover its astonishing power now...](  Lowered Expectations There's a saying, "History doesn't repeat itself, but if often rhymes." Well, there was a great lesson to be learned in 2019 that didn't rhyme but shouldn't be repeated. "Euphoria is the enemy." Investors must temper their expectations. In 2019, pot stocks dropped like stones because of lofty projections. As companies ramped up spending, they failed quarter after quarter to meet Wall Street's forecasts. This scenario might do more than just rhyme in 2020 as Ontario continues to be worthy of pot stock scorn. Ontario is the most populous province in Canada. It's home to roughly 40% of the country's population. But it has a mere 24 dispensaries - one for every 600,000 residents. Now, the province announced it would begin authorizing 20 new stores per month starting in April. And companies will be allowed to operate 75 dispensaries each by September 2021. Obviously, this news received a thumbs-up from investors. Canopy has blamed the lack of Ontario stores as one of the biggest drags on earnings. But before we're guilty of putting the cart before the horse, those 20 new stores per month starting in April are below the 40 new store openings per month starting in January that Canopy forecast. So keep that in perspective. Out of the gate, edibles and vape pens are poised to win big. Vape pens could capture 20% of the market, as edibles snag 10% to 15%. For now, dried flower will remain the dominant force though, accounting for 50% of sales. But there's an important piece to keep in mind. For now, alcohol infused beverages won't be available. Nor will infused energy drinks or any high-potency product. In the U.S., infused beverages account for less than 1% of the market. In Canada, the current forecast is that beverages might grab 2% to 3% of the market early on. And then it's a game of wait-and-see. Don't expect Cannabis 2.0 to right the ship overnight. We have a tremendous opportunity. But I am skeptical of the market's reaction to those first earnings reports after Cannabis 2.0 launches with the obstacles in the road. It's hard for me to view any Canadian licensed producer as overvalued at current prices. I'm merely warning, don't get caught chasing. Pick your spots and err on the side of caution. The High Five This week, we're going to do something a little different for our "High Five." My team and I traveled to Las Vegas last week to attend the 8th annual Marijuana Business Conference and Expo (MJBizCon). This is the largest cannabis conference in the world and is attended by roughly 30,000 industry professionals. So today, we're going to share with you our top five takeaways from this year's event... 1) The 2020 Diet: "Losing weight" is the most common New Year's resolution. Look for pot stocks to make this their focus in 2020 too. In 2019, companies were all about growth at any cost. Now belt tightening is coming. We've already seen several mergers and acquisitions renegotiated or abandoned. Expect that to continue. 2) CBD Crackdown: The legality of CBD is hazy. And the Food and Drug Administration (FDA) cited the need for more research be done into the safety of CBD consumption. The FDA will be forced to make a ruling on CBD. And the agency will likely begin targeting CBD-infused food and beverage products, as well as supplements. Any health benefits and claims will see increased scrutiny and warnings. 3) Illinois Gets It Right: We've seen failure after failure when it comes to new marijuana market launches. California stands out as the biggest dud. Its rollout was mired in missteps and red tape. But there is hope - though tempered - that when Illinois adult-use sales kick off to start the new year, it'll be one of the few success stories, like Colorado or Nevada. 4) Show Me the Money! For cannabis companies, 2020 will be all about profitability, not growth or expansion. And that will mean focusing more on efficiencies. Expect big investments into enterprise resource management software and platforms. And I think those multistate operators that have remained laser-focused on only one or two markets will have the advantage. 5) Which Side Do You Choose? On one hand, there's the medical marijuana market. On the other, there's adult-use or recreational. Very few companies will be able to successfully conquer both. Most companies in the U.S. and Canada are going to have to make a choice. Are they going to focus on recreational or medical? 2020 will see the beginning of those distinctions. Over the past month, our benchmark, the Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF), is in the green!  [Chart - Horizon Marijuana Index]  It's been quite some time since we've been able to celebrate that. We can thank the Cannabis 2.0 optimism for helping pot stock shares push off from their multiyear lows. Now, despite all the turbulence and share price declines in 2019, most people at the world's largest cannabis conference shrugged it off. Because the reality is that this is a nascent North American industry. As the adage goes, "You have to learn to walk before you can run." Canada's national, legal adult-use market is only 14 months old. It's suffered its share of bumps and bruises. But like any 14-month-old, it's still learning how to walk on new legs. In the U.S., the market fractured. There are 33 states that have legalized medical use and 11 that have legalized adult-use. The race was on in 2019 for companies to expand their footprint to as many of those markets as possible. And they stumbled. They tried to run before they could walk. Cannabis is both a marathon and a sprint. We know a change at the federal level is coming to the U.S. It's merely a matter of when. And we know that Canada has high hopes for Cannabis 2.0 legalization. But it won't be the savior overnight. In 2020, pot stocks will be making long-measured strides, pacing themselves for the marathon ahead. The sprint is over. Now the endurance race begins. If you have a pot stock in mind that you'd like me to discuss here, click the comment button below. Here's to high returns, Matthew   [Leave a Comment](  [Facebook]( [Twitter]( [Share](mailto:?subject=A%20great%20piece%20from%20Profit%20Trends...&body=From%20Profit%20Trends:%0D%0A%0D%0ANow%20that%20Canadian%20shelves%20are%20stuffed%20with%20all%20kinds%20of%20new%20cannabis%20products,%20what%20should%20investors%20really%20expect?%0D%0A%0D ?src=shared) [Jewish Marijuana Leaf]( [Medical Marijuana Opportunity Out of Israel]( Matthew Carr | December 12, 2019 Israel is a hotbed for medical marijuana companies and research. [Read More](  [Energy Storage]( [4 Energy Storage Stocks]( David Fessler | December 11, 2019 Energy storage has arrived and is here to stay. You should consider making it part of your investment portfolio. [Read More](  [5G Fast]( [What is the FCC's "5G FAST" Plan?]( David Fessler | December 10, 2019 5G, the coming fifth-generation wireless network, promises huge disruptions around the world. And the U.S. is staking its claim. [Read More](   [A MUST-READ FOR RETIREES!]( [The Best Book of Retirement Secrets]( There's a ton of @#$% they're not telling you about how to have the retirement you deserve... And it's all revealed right here in this brand-new [FREE BOOK*](, written by America's No. 1 Retirement Expert. [Click here to claim your copy TODAY.]( *Limited quantity!   You are receiving this email because you subscribed to Profit Trends. To unsubscribe from Profit Trends, [click here]( ). Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Profit Trends | Attn: Member Services | 105 West Monument Street | Baltimore, MD 21201 North America: [1.800.589.3430]( | International: [+1.443.353.4334]( | Fax: [1.410.329.1923]( Website: [profittrends.com]( Keep the emails you value from falling into your spam folder. [Whitelist Profit Trends](. © 2019 The Oxford Club LLC All Rights Reserved  [Oxford Club] The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201. Â